KEIRA O'REILLY: Open Payments
NPI 1891378873 · GREENWICH, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 14 payments from 8 companies in 2025. Trend: 2023 $705 · 2024 $678 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| Exeltis, USA Inc. | 2 | $125 |
| MILLICENT US INC | 3 | $47 |
| Sage Therapeutics, LLC | 2 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| PFIZER INC. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $24 |
| Supernus Pharmaceuticals, Inc. | 1 | $18 |
Products named: SLYND, TYBLUME, ZURZUVAE, MYFEMBREE, INTRAROSA, ABRYSVO, Veozah, Lynkuet.
Industry payments across CT — which companies pay providers there.
